Rapid improvement of acute pulmonary edema with sublingual captopril

R. J. Hamilton, W. A. Carter, E. John Gallagher

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Objective: To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide. Methods: Prospective, randomized, double-blind, placebo-controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually. Every 5 minutes a clinical APE distress score (APEX) was obtained. Results: Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0.001, F = 14.5, one-way (repeated-measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43% (i.e., to 57% of initial distress); the group given the current standard regimen plus placebo improved only 25% (i.e., to 75% of initial distress; p = 0.03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9%) vs the placebo patients (20%), which did not achieve significance (p = 0.10, Fisher's exact test). Conclusion: In APE, the addition of sublingual captopril to the standard regimen of O2, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
JournalAcademic Emergency Medicine
Volume3
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

Captopril
Pulmonary Edema
Placebos
Furosemide
Nitrates
Morphine
Analysis of Variance
Urban Hospitals
Controlled Clinical Trials
Artificial Respiration
Teaching Hospitals
Respiratory Insufficiency

Keywords

  • angiotensin- converting enzyme inhibitor
  • captopril
  • congestive heart failure
  • pulmonary edema

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Rapid improvement of acute pulmonary edema with sublingual captopril. / Hamilton, R. J.; Carter, W. A.; Gallagher, E. John.

In: Academic Emergency Medicine, Vol. 3, No. 3, 1996, p. 205-212.

Research output: Contribution to journalArticle

@article{2cba373e0d4246d0bf13b2945ddd41cf,
title = "Rapid improvement of acute pulmonary edema with sublingual captopril",
abstract = "Objective: To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide. Methods: Prospective, randomized, double-blind, placebo-controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually. Every 5 minutes a clinical APE distress score (APEX) was obtained. Results: Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0.001, F = 14.5, one-way (repeated-measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43{\%} (i.e., to 57{\%} of initial distress); the group given the current standard regimen plus placebo improved only 25{\%} (i.e., to 75{\%} of initial distress; p = 0.03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9{\%}) vs the placebo patients (20{\%}), which did not achieve significance (p = 0.10, Fisher's exact test). Conclusion: In APE, the addition of sublingual captopril to the standard regimen of O2, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.",
keywords = "angiotensin- converting enzyme inhibitor, captopril, congestive heart failure, pulmonary edema",
author = "Hamilton, {R. J.} and Carter, {W. A.} and Gallagher, {E. John}",
year = "1996",
language = "English (US)",
volume = "3",
pages = "205--212",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Rapid improvement of acute pulmonary edema with sublingual captopril

AU - Hamilton, R. J.

AU - Carter, W. A.

AU - Gallagher, E. John

PY - 1996

Y1 - 1996

N2 - Objective: To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide. Methods: Prospective, randomized, double-blind, placebo-controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually. Every 5 minutes a clinical APE distress score (APEX) was obtained. Results: Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0.001, F = 14.5, one-way (repeated-measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43% (i.e., to 57% of initial distress); the group given the current standard regimen plus placebo improved only 25% (i.e., to 75% of initial distress; p = 0.03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9%) vs the placebo patients (20%), which did not achieve significance (p = 0.10, Fisher's exact test). Conclusion: In APE, the addition of sublingual captopril to the standard regimen of O2, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.

AB - Objective: To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide. Methods: Prospective, randomized, double-blind, placebo-controlled clinical trial in an urban teaching hospital ED. Adults brought to the ED with APE were given captopril or placebo sublingually. Every 5 minutes a clinical APE distress score (APEX) was obtained. Results: Over the first 40 minutes of treatment, the mean APEXs were significantly better for the patients given captopril [p < 0.001, F = 14.5, one-way (repeated-measures) analysis of variance (ANOVA)]. At 30 minutes, the patients given captopril had a mean APEX improvement of 43% (i.e., to 57% of initial distress); the group given the current standard regimen plus placebo improved only 25% (i.e., to 75% of initial distress; p = 0.03, multiway ANOVA). In addition, there was less respiratory failure necessitating mechanical ventilation in the captopril patients (9%) vs the placebo patients (20%), which did not achieve significance (p = 0.10, Fisher's exact test). Conclusion: In APE, the addition of sublingual captopril to the standard regimen of O2, nitrates, morphine, and furosemide produces more rapid clinical improvement than does the standard regimen alone.

KW - angiotensin- converting enzyme inhibitor

KW - captopril

KW - congestive heart failure

KW - pulmonary edema

UR - http://www.scopus.com/inward/record.url?scp=0029876913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029876913&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 205

EP - 212

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 3

ER -